Alps Advisors Inc. Acquires New Holdings in Albemarle Co. (ALB)

Alps Advisors Inc. acquired a new stake in shares of Albemarle Co. (NYSE:ALB) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 1,994 shares of the specialty chemicals company’s stock, valued at approximately $255,000.

Several other institutional investors and hedge funds also recently bought and sold shares of ALB. Thompson Davis & CO. Inc. increased its holdings in Albemarle by 650.0% in the 3rd quarter. Thompson Davis & CO. Inc. now owns 750 shares of the specialty chemicals company’s stock worth $102,000 after buying an additional 650 shares during the period. SeaCrest Wealth Management LLC acquired a new position in Albemarle in the 4th quarter worth approximately $103,000. Advisory Services Network LLC increased its holdings in Albemarle by 43.7% in the 2nd quarter. Advisory Services Network LLC now owns 1,273 shares of the specialty chemicals company’s stock worth $134,000 after buying an additional 387 shares during the period. Howe & Rusling Inc. increased its holdings in Albemarle by 2,038.0% in the 3rd quarter. Howe & Rusling Inc. now owns 1,069 shares of the specialty chemicals company’s stock worth $146,000 after buying an additional 1,019 shares during the period. Finally, Renaissance Investment Group LLC acquired a new position in Albemarle in the 4th quarter worth approximately $201,000. Hedge funds and other institutional investors own 87.38% of the company’s stock.

Shares of Albemarle Co. (ALB) opened at $111.72 on Thursday. The company has a debt-to-equity ratio of 0.35, a current ratio of 2.11 and a quick ratio of 1.56. Albemarle Co. has a 52-week low of $91.02 and a 52-week high of $144.99. The company has a market capitalization of $11,983.25, a P/E ratio of 26.84, a price-to-earnings-growth ratio of 1.43 and a beta of 1.56.

ALB has been the topic of several research reports. Royal Bank of Canada reiterated a “buy” rating and issued a $149.00 price target on shares of Albemarle in a report on Wednesday, October 18th. Jefferies Group reiterated a “buy” rating on shares of Albemarle in a report on Tuesday, October 24th. BMO Capital Markets initiated coverage on shares of Albemarle in a report on Tuesday, October 24th. They issued an “outperform” rating and a $160.00 price target on the stock. Robert W. Baird reiterated a “hold” rating and issued a $135.00 price target on shares of Albemarle in a report on Wednesday, November 1st. Finally, UBS Group increased their price target on shares of Albemarle from $123.00 to $150.00 and gave the stock a “neutral” rating in a report on Thursday, November 9th. Ten investment analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company. Albemarle presently has a consensus rating of “Buy” and a consensus price target of $127.88.

TRADEMARK VIOLATION WARNING: This article was published by Week Herald and is owned by of Week Herald. If you are viewing this article on another domain, it was stolen and republished in violation of U.S. and international trademark & copyright law. The original version of this article can be viewed at https://weekherald.com/2018/02/15/alps-advisors-inc-acquires-new-holdings-in-albemarle-co-alb.html.

Albemarle Profile

Albemarle Corporation is a global developer, manufacturer and marketer of highly-engineered specialty chemicals. The Company operates through three segments: Lithium and Advanced Materials, Bromine Specialties and Refining Solutions. Lithium and Advanced Materials segment consist of two product categories: Lithium and Performance Catalyst Solutions.

Institutional Ownership by Quarter for Albemarle (NYSE:ALB)

Receive News & Ratings for Albemarle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply